• 1
    Hricak H, Choyke PL, Eberhardt SC, Leibel SA, Scardino PT. Imaging prostate cancer: a multidisciplinary perspective. Radiology 2007; 243: 2853
  • 2
    Villers A, Puech P, Mouton D, Leroy X, Ballereau C, Lemaitre L. Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings. J Urol 2006; 176: 24327
  • 3
    Kirkham AP, Emberton M, Allen C. How good is MRI at detecting and characterising cancer within the prostate? Eur Urol 2006; 50: 116374
  • 4
    Hricak H. MR imaging and MR spectroscopic imaging in the pre-treatment evaluation of prostate cancer. Br J Radiol 2005; 78 (Special issue): S10311
  • 5
    US Patent Application no. 60/574853, provisional application: Implementation of ovarian HistoScanning. Filed 27 May 2004. Pending PCT application HIS-003-PCT/IB2005/001506 Method and device for tissue characterization. Pending PCT application HIS-002-PCT/IB2004/001127 Method and System for Selecting and Recording Biopsy Sites in a Body Organ.
  • 6
    Braeckman J, Autier P, Garbar C et al. Computer aided ultrasonography (HistoScanning): a novel technology for locating and characterising prostate cancer. BJU Int 2008; 101: 2938
  • 7
    Iczkowski KA, Hossain D, Torkko KC et al. Preoperative prediction of unifocal, unilateral, margin-negative, and small volume prostate cancer. Urology 2008; 71: 116671
  • 8
    Cheng L, Poulos CK, Pan C et al. Preoperative prediction of small volume cancer (less than 0.5 ml) in radical prostatectomy specimens. J Urol 2005; 174: 898902
  • 9
    Nelson B, Shapell S, Chang S et al. Tumour volume is an independent predictor of prostate-specific antigen recurrence in patients undergoing radical prostatectomy for clinically localised prostate cancer. BJU Int 2006; 97: 116972
  • 10
    Stamey TA, McNeal JE, Yemoto CM et al. Biological determinants of cancer progression in men with prostate cancer. JAMA 1999; 281: 1395400
  • 11
    Bostwick DG, Montironi R. Evaluating radical prostatectomy specimens: therapeutic and prognostic importance. Virchow Arch 1997; 430: 116
  • 12
    Renshaw AA, Chang H, D’Amico AV. An abbreviated protocol for processing radical prostatectomy specimens. J Urol Pathol 1996; 5: 18392
  • 13
    Roemeling S, Roobol MJ, Kattan MW, Van Der Kwast TH, Steyerberg EW, Schröder FH. Nomogram use for the prediction of indolent prostate cancer: impact on screen-detected populations. Cancer 2007; 110: 221821
  • 14
    Djavan B, Milani S, Remzi M. Prostate biopsy: who, how and when: an update. Can J Urol 2005; 12 (Suppl. 1): S448
  • 15
    Sebo TJ, Bock BJ, Cheville JC, Lohse C, Wollan P, Zincke H. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy. J Urol 2000; 163: 1748
  • 16
    Venkitaraman R, Norman A, Woode-Amissah R et al. Predictors of histological disease progression in untreated, localized prostate cancer. J Urol 2007; 178: 8337
  • 17
    Hayashi N, Urashima M, Kuruma H et al. The maximum tumour length in biopsy cores as a predictor of outcome after radical prostatectomy. BJU Int 2008; 101: 17580
  • 18
    Lizzi FL, Astor M, Feleppa EJ, Shao M, Kalisz A. Statistical framework for ultrasonic spectral parameter imaging. Ultrasound Med Biol 1997; 23: 137182
  • 19
    Schmitz G, Ermert H, Senge T. Tissue characterization and imaging of the prostate using radio frequency ultrasonic signals. IEEE Trans Ultrason Ferroelec Freq Control 1999; 46: 12638
  • 20
    Kattan MW, Wheeler TM, Scardino PT. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol 1999; 17: 1499507